Showing 1 posts of 1 posts found.
The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO